Traditional safety systems and manual workflows can struggle to keep pace with increasingly complex product portfolios and evolving regulatory requirements. They need connected, scalable and intelligent pharmacovigilance ecosystems that support efficient case management, regulatory compliance and informed safety decisions.

This is driving greater interest in pharmacovigilance technology modernization, cloud-based safety platforms and automation-enabled drug safety operations.

Why Pharmacovigilance Technology Matters

Global drug safety operations involve multiple interconnected activities, including individual case safety report (ICSR) processing, adverse event management, regulatory submissions, signal detection and safety reporting.

As reporting volumes increase and regulatory expectations evolve, fragmented systems and manual processes can create operational challenges.

Common challenges include:

• Increasing volumes of adverse event reports and complex case-processing requirements.
• Multiple safety databases and disconnected workflows across geographies.
• Time-intensive manual processes that affect operational efficiency.
• Challenges in maintaining data consistency, traceability and audit readiness.
• The need to meet changing global pharmacovigilance regulations.
• Limited visibility across safety operations and performance metrics.

Modern pharmacovigilance platforms help address these challenges by connecting safety workflows, enabling automation and providing greater operational visibility.

The Role of Oracle Argus in Modern Drug Safety Operations

Oracle Argus has long been an established technology platform for pharmaceutical safety operations. Its evolving capabilities, including cloud-based solutions and integrated safety workflows, offer organisations opportunities to modernize how they manage drug safety information.

Oracle Life Sciences Safety One Argus brings together capabilities across safety intake, case management, global safety reporting and regulatory compliance.

Built on Oracle Cloud Infrastructure, the solution incorporates automation, AI and advanced analytics to support more connected and scalable safety operations.

For pharmaceutical companies, adopting or upgrading such platforms requires careful planning. Data integrity, system configuration, validation, testing and business continuity must remain central to the transition.

Technology modernization must strengthen pharmacovigilance operations without compromising patient safety or regulatory obligations.

Why Expert Implementation and Migration Support Matter

Organisations must assess the impact of system changes on existing workflows, evaluate configurations, plan validation activities, conduct testing and prepare teams for go-live.

An effective migration or upgrade strategy typically includes:

1. Impact assessment and planning
Understanding the implications of the new system version, identifying operational dependencies and establishing a structured migration roadmap.

2. Configuration review
Evaluating existing configurations and workflows to ensure alignment with business requirements and the capabilities of the upgraded platform.

3. Validation and testing support
Establishing appropriate validation plans and testing system functionality to support data integrity, quality and regulatory expectations.

4. Issue resolution and go-live readiness
Identifying and addressing implementation challenges, preparing stakeholders and ensuring operational readiness before deployment.

5. Business continuity
Maintaining ongoing pharmacovigilance activities throughout the transition, minimizing disruption to critical drug safety operations.
The combination of technology expertise and pharmacovigilance domain knowledge is essential to achieving these outcomes.

Navitas Life Sciences: Enabling Pharmacovigilance Technology Transformation

Navitas Life Sciences’ understands that pharmacovigilance technology is most effective when supported by strong implementation expertise and an understanding of real-world safety operations.

Our pharmacovigilance technology and consulting capabilities help pharmaceutical organisations navigate technology transitions while maintaining a focus on quality, compliance and operational continuity.

Our expertise includes supporting critical technology initiatives through:

• Pharmacovigilance technology implementation and upgrade support.
• Safety database migration and transition planning.
• System impact assessment and configuration review.
• Validation planning and testing support.
• Issue resolution and go-live readiness.
• Technology consulting aligned with pharmacovigilance requirements.

By bringing together technology capabilities and pharmacovigilance expertise, we help organisations approach safety system modernization with greater confidence.

A Real-World Example: Supporting Piramal Critical Care's Oracle Argus Upgrade

A recent engagement demonstrates how structured planning and collaborative execution can enable successful pharmacovigilance technology transformation.

Navitas Life Sciences successfully supported Piramal Critical Care (PCC), a subsidiary of Piramal Pharma Limited, in migrating to an updated version of Oracle Life Sciences Safety One Argus.

The project was completed ahead of schedule, with no disruption to ongoing pharmacovigilance operations.

 

Looking to modernize your pharmacovigilance technology or strengthen your safety operations?

Connect with Navitas Life Sciences to explore how our pharmacovigilance technology and consulting expertise can support your transformation journey.

 

Learn more about our services and solutions by reaching out to us at This email address is being protected from spambots. You need JavaScript enabled to view it..